2011 Fiscal Year Final Research Report
Analysis of helper T cell subset in severe asthma for the development of new immunotherapy
Project/Area Number |
21390255
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Chiba University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KAGAMI Shin-ichiro 千葉大学, 医学部附属病院, 助教 (30375654)
HIROSE Koichi 千葉大学, 医学部附属病院, 講師 (90400887)
WATANABE Norihiko 千葉大学, 大学院・医学研究院, 准教授 (20375653)
SUTO Akira 千葉大学, 大学院・医学研究院, 助教 (50447306)
|
Project Period (FY) |
2009 – 2011
|
Keywords | 喘息 / IL-22 / IL-21 / c-Maf / T細胞 / 免疫療法 |
Research Abstract |
Asthma is chronic airway inflammation characterized by eosinophil infiltration, mucus hypersecretion, and airway hyperresponsiveness (AHR) to a variety of stimuli. These characteristics are mainly mediated by antigen-specific Th2 cells and their cytokines including IL-4, IL-5, and IL-13. Moreover, we and others have shown that Th17 cells induce neutrophilc airway inflammation in part through the production of IL-17A. More recently, IL-22, one of Th17 cell-derived cytokines with both proinflammatory and anti-inflammatory properties, has been shown to be detected in the airways in a murine model of asthma. However, the role of IL-22 in the regulation of allergic airway inflammation remains largely unknown. In this study, we found that IL-22 was produced by CD4^+ T cells infiltrating in the airways upon antigen challenge, that the neutralization of IL-22 by anti-IL-22 antibody in the effector phase enhanced antigen-induced eosinophil recruitment into the airways, and that intranasal administration of recombinant IL-22 inhibited antigen-induced eosinophil recruitment into the airways. We also found that anti-IL-22 antibody enhanced antigen-induced IL-25 production in the airways, which is known to enhance Th2-type immune responses in the airways, and indeed co-injection of anti-IL-25 antibody reversed the enhancing effect of anti-IL-22 antibody on antigen-induced eosinophil recruitment into the airways. Finally, we found that IL-22 inhibited IL-13-mediated enhancement of IL-25 expression in LPS-stimulated lung epithelial cell line MLE-15 cells. Our results suggest that IL-22 attenuates antigen-induced airway inflammation in part by inhibiting the expression of IL-25 in lung epithelial cells.
|
-
-
[Journal Article] IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation.2011
Author(s)
Takahashi K, Hirose K, Kawashima S, Niwa Y, Wakashin H, Iwata A, Tokoyoda K, Renauld JC, Iwamoto I, Nakayama T, Nakajima H
-
Journal Title
J. Allergy Clin. Immunol
Volume: 128
Pages: 1067-76
DOI
Peer Reviewed
-
-
-
-
[Journal Article] B and T lymphocyte attenuator suppresses IL-21 production from follicular helper T cells and subsequent humoral immune responses2010
Author(s)
Kashiwakuma D, Suto A, Hiramatsu Y, Ikeda K, Takatori H, Suzuki K, Kagami S, Hirose K, Watanabe N, Iwamoto I, Nakajima H
-
Journal Title
J. Immunol
Volume: 185
Pages: 2730-2736
DOI
Peer Reviewed
-
[Journal Article] Role of Th2 cells in IgG4-related lacrimal gland enlargement2010
Author(s)
Kanari H, Kagami S, Kashiwakuma D, Oya Y, Furuta S, Ikeda K, Suto A, Suzuki K, Hirose K, Watanabe N, Okamoto Y, Yamamoto S, Iwamoto I, Nakajima H
-
Journal Title
Int. Arch. Allergy Immunol
Volume: 152
Pages: s47-53
DOI
Peer Reviewed
-
[Journal Article] c-Maf activates the promoter and enhancer of IL-21 gene while TGF-β inhibits c-Maf-induced IL-21expression in CD4^+ T cells2010
Author(s)
Hiramatsu Y, Suto A, Kashiwakuma D, Kanari H, Kagami S, Ikeda K, Hirose K, Watanabe N, Grusby MJ, Iwamoto I, Nakajima H
-
Journal Title
J. Leukoc. Biol
Volume: 87
Pages: 703-712
DOI
Peer Reviewed
-
-
-
[Journal Article] Protective roles of B and T lymphocyte attenuator (BTLA) in NKT cell-mediated experimental hepatitis2010
Author(s)
Iwata A, Watanabe N, Oya Y, Owada T, Ikeda K, Suto A, Kagami S, Hirose K, Kanari H, Kawashima S, Nakayama T, Taniguchi M, Iwamoto I, Nakajima H
-
Journal Title
J. Immunol
Volume: 184
Pages: 127-133
DOI
Peer Reviewed
-
-
-
-
-
[Patent(Industrial Property Rights)] 関節リウマチに対する抗IL-6受容体抗体療法の有効性の予測方法2011
Inventor(s)
中島裕史, 池田啓, 加々美新一郎, 鈴木快枝, 中山俊憲, 岩本逸夫, 古田俊介, 小原收, 野中謙, 山下政克, 的場亮
Industrial Property Rights Holder
千葉大学
Industrial Property Number
特願2011-156921
Filing Date
2011-07-15